Handbook home
BioDesign Innovation (MGMT90231)
Graduate courseworkPoints: 37.5Dual-Delivery (Parkville)
From 2023 most subjects will be taught on campus only with flexible options limited to a select number of postgraduate programs and individual subjects.
To learn more, visit COVID-19 course and subject delivery.
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable(opens in new window)
Contact information
February
Overview
Availability | February - Dual-Delivery |
---|---|
Fees | Look up fees |
BioDesign Innovation is a “real world”, team-based subject in creating successful medical devices. Teams will consist of 2-3 students from the MBA program and 2-3 students from engineering disciplines, along with individuals with medical and law backgrounds to conceive and design an innovative medical device, taking it through all steps of development. The teams will create an engineering prototype of their invention, draft a provisional patent application, and compose a detailed business plan; team members are expected to contribute primarily according their specialisation.
BioDesign Innovation is given over three terms of one academic year and is composed of frontal lectures, practical training, and a guided project. The subject is taught by a combination of academics and guest speakers such as medical device entrepreneurs, corporate executives, intellectual property attorneys and venture capitalists. As such, it provides a unique opportunity to gain real world experience while still in an academic environment.
This subject is only available to students admitted to MC-BAPT, or students with permission of the MBA course coordinator. There is an application process for this subject, and students are required to have achieved a H2B average or better in their course.
Intended learning outcomes
Having completed this unit the student should be able to:
- Search, analyse and document clinical practice, engineering science and relevant literature in order to determine the need for further research and development in a chosen clinical area.
- Devise a methodology of investigation to improve knowledge or understanding of a chosen interdisciplinary topic.
- Collect and analyse a range of data (both qualitative and quantitative) to improve collective understanding of a chosen topic.
- Build a device or write software that helps to technologically address a clinical need.
- Develop a business plan, including market overview, regulation and reimbursement strategies and intellectual property (IP) strategies.
- Write a project report that follows good engineering science practice.
- Present an oral presentation of the findings of an investigation to an audience of peers or lay people.
Last updated: 31 January 2024
Eligibility and requirements
Prerequisites
All of
Code | Name | Teaching period | Credit Points |
---|---|---|---|
BUSA90026 | Business Strategy |
April (Dual-Delivery - Parkville)
July (On Campus - Parkville)
September (On Campus - Parkville)
April (Dual-Delivery - Parkville)
|
12.5 |
BUSA90074 | Global Business Economics |
September (On Campus - Parkville)
January (Dual-Delivery - Parkville)
April (Dual-Delivery - Parkville)
|
12.5 |
BUSA90227 | Operations |
April (Dual-Delivery - Parkville)
July (On Campus - Parkville)
January (Dual-Delivery - Parkville)
September (On Campus - Parkville)
|
12.5 |
Corequisites
None
Non-allowed subjects
None
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 31 January 2024
Assessment
Description | Timing | Percentage |
---|---|---|
One team-based written assignment on a clinical need, due in Week 8 or 9
| From Week 8 to Week 9 | 10% |
One team-based written assignment on the proposed medical device, due in Week 12 or 13
| From Week 12 to Week 13 | 10% |
One team-based oral presentation
| Week 22 | 20% |
A technical oral presentation (including Q&A), due in Week 32 or 33
| From Week 32 to Week 33 | 10% |
A lay person oral presentation, due in Week 33 or 34
| From Week 33 to Week 34 | 10% |
A professional project report
| Week 34 | 34% |
Last updated: 31 January 2024
Dates & times
- February
Principal coordinator Kwang Lim Mode of delivery Dual-Delivery (Parkville) Contact hours 90 hours Total time commitment 510 hours Teaching period 28 February 2022 to 29 August 2022 Last self-enrol date 5 April 2022 Census date 8 April 2022 Last date to withdraw without fail 1 July 2022 Assessment period ends 10 September 2022 February contact information
Last updated: 31 January 2024
Further information
- Texts
Prescribed texts
There are no specifically prescribed or recommended texts for this subject.
Last updated: 31 January 2024